Evolution of the Brazilian Drug Control System: Case Study of ADB-FUBIATA, a Psychotropic NPS
Introduction: The New Psychoactive Substances (NPS) market is very dynamic, requiring new legislative approaches to tackle the drug problem. Brazil has improved the Drug Scheduling System, making the process more agile, which allows fast scheduling of NPS. The Working Group conceived between Anvisa...
Saved in:
| Main Authors: | M.L.S. Macedo, L. dos Santos Lopes, G.H. Giudice, R. de Morais Souza |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Emerging Trends in Drugs, Addictions, and Health |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667118223000545 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychotropic drugs and bone
by: R.W. Gasser, et al.
Published: (2024-12-01) -
Side effects of psychotropic drugs on eye
by: A.A. Petukhova, et al.
Published: (2021-03-01) -
Use of psychotropic drugs among Indigenous and Quilombola communities in Brazil
by: Gabriela da Silva Gonçalves Loures, et al.
Published: (2024-12-01) -
Psychotropic Drugs in Dermatology Part 1: Anti-depressants and Mood Stabilisers
by: Varsha L. Kenkare, et al.
Published: (2025-01-01) -
Unraveling the liver metabolomic profile of ADB-BUTINACA-induced hepatotoxicity
by: Yilei Fan, et al.
Published: (2024-12-01)